The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda. Under Texas law, companies are required to hold annual general meetings ...

Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...

UnitedHealth Group Inc. promoted a new leader for the company’s Medicaid insurance segment, filling a role that was vacant ...

The S&P 500 extended gains slightly on Wednesday following the release of minutes from the last Federal Reserve meeting, ...

The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain ...

Like his predecessor, Griffith has backed efforts by pharmacists, dentists and other providers to fend off provider network ...

The Department of Justice is interviewing former employees as part of its criminal Medicare fraud probe into UnitedHealth, according to ...

UnitedHealth Group shares fell about 2% in trading Wednesday morning after the Wall Street Journal reported new details on a previously reported criminal investigation by the U.S. Department of ...

Merry Kogut filed a derivative suit on June 14, alleging that UnitedHealth's leadership failed to disclose a Department of ...

UnitedHealth Group (NYSE: UNH) has spent a significant amount of time in the sick bay for the first half of 2025, but it’s ...

The lawsuit alleges that the defendants forced healthcare providers to accept payments made via prepaid debit cards which ...

The Dow Jones Industrial Average was erasing most of its morning gains ahead of midday trading on Wednesday. Here's a look at what is putting pressure on the blue-chip index: UnitedHealth Group Inc.'s ...